Your browser doesn't support javascript.
loading
Adjuvant therapy for colorectal cancer--is there a place for a Northern Ireland study?
Wilson, R H; Houston, R F; Moorehead, R J.
Afiliación
  • Wilson RH; Northern Ireland Centre for Clinical Oncology, Belvoir Park Hospital, Belfast.
Ulster Med J ; 63(1): 44-51, 1994 Apr.
Article en En | MEDLINE | ID: mdl-8658995
Survival from colorectal cancer has not improved over the last four decades despite advances in surgery and anaesthesia. The answer to the question whether adjuvant chemotherapy and radiotherapy will improve survival from the disease can only come from randomised, controlled trails. In the future, immunotherapy and gene therapy may be of benefit but these are still many years from the clinical arena. We believe that current evidence suggests that patients with Dukes B and C colorectal cancer should be entered into trials of adjuvant therapy. This evidence is reviewed below among with estimates of the impact that adjuvant therapy would have on the outcome from this disease in Northern Ireland.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Colorrectales Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ulster Med J Año: 1994 Tipo del documento: Article Pais de publicación: Irlanda del Norte

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Colorrectales Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ulster Med J Año: 1994 Tipo del documento: Article Pais de publicación: Irlanda del Norte